inhibitor polimerazy poli(ADP-rybozy)

Also known as PARP Inhibitors, Poly (ADP-ribose) Polymerase Inhibitors, Poly (ADP-ribosylation) Inhibitors, Inhibitors of Poly (ADP-ribose) Polymerases, Poly(ADP-ribose) Polymerase Inhibitor

pharmacological enzyme inhibitors of poly (ADP-ribose) polymerases

Research

19,637 papers

PARP inhibitor resistance: the underlying mechanisms and clinical implications.Molecular cancer · 2020
Clinical approaches to overcome PARP inhibitor resistance.Molecular cancer · 2025
PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells.Trends in cell biology · 2019
PARP inhibitor combination therapy.Critical reviews in oncology/hematology · 2016
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer.Nature communications · 2023

via PubMed

Wikidata facts

Show 1 more fact

Commons category: PARP inhibitors

Available in 10 languages

via Wikidata sitelinks · CC0

Connections

non-small-cell lung carcinoma

Entity

pharmacology

Entity

Similar entities

Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).

juvenile polyposis syndrome

Entitydist 0.68

inhibitor polimerazy poli(ADP-rybozy)

Research

Wikidata facts

Available in 10 languages

Connections

What links here355 pages

Similar entities

Categories

Similar entities

What links here355 pages